Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 160

1.

Ex Vivo Four-Dimensional Lung Cancer Model Mimics Metastasis.

Mishra DK, Creighton CJ, Zhang Y, Chen F, Thrall MJ, Kim MP.

Ann Thorac Surg. 2015 Feb 18. pii: S0003-4975(15)00006-5. doi: 10.1016/j.athoracsur.2014.08.085. [Epub ahead of print]

PMID:
25701100
[PubMed - as supplied by publisher]
2.

Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stroma.

Chen Y, Terajima M, Yang Y, Sun L, Ahn YH, Pankova D, Puperi DS, Watanabe T, Kim MP, Blackmon SH, Rodriguez J, Liu H, Behrens C, Wistuba II, Minelli R, Scott KL, Sanchez-Adams J, Guilak F, Pati D, Thilaganathan N, Burns AR, Creighton CJ, Martinez ED, Zal T, Grande-Allen KJ, Yamauchi M, Kurie JM.

J Clin Invest. 2015 Mar 2;125(3):1147-1162. doi: 10.1172/JCI74725. Epub 2015 Feb 9.

PMID:
25664850
[PubMed - as supplied by publisher]
3.

Ror2 regulates branching, differentiation, and actin-cytoskeletal dynamics within the mammary epithelium.

Roarty K, Shore AN, Creighton CJ, Rosen JM.

J Cell Biol. 2015 Feb 2;208(3):351-66. doi: 10.1083/jcb.201408058. Epub 2015 Jan 26.

PMID:
25624393
[PubMed - in process]
4.

NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma.

Zhao S, Kurenbekova L, Gao Y, Roos A, Creighton CJ, Rao P, Hicks J, Man TK, Lau C, Brown AM, Jones SN, Lazar AJ, Ingram D, Lev D, Donehower LA, Yustein JT.

Oncogene. 2015 Jan 12. doi: 10.1038/onc.2014.429. [Epub ahead of print]

PMID:
25579177
[PubMed - as supplied by publisher]
5.

Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.

Giuliano M, Herrera S, Christiny P, Shaw C, Creighton CJ, Mitchell T, Bhat R, Zhang X, Mao S, Dobrolecki LE, Al-Rawi A, Chen F, Veneziani BM, Zhang X, Hilsenbeck SG, Contreras A, Gutierrez C, Jeselsohn RM, Rimawi MF, Osborne C, Lewis MT, Schiff R, Trivedi MV.

Breast Cancer Res. 2015 Jan 9;17(1):3. [Epub ahead of print]

PMID:
25572662
[PubMed - as supplied by publisher]
Free PMC Article
6.

In-silico QTL mapping of postpubertal mammary ductal development in the mouse uncovers potential human breast cancer risk loci.

Hadsell DL, Hadsell LA, Olea W, Rijnkels M, Creighton CJ, Smyth I, Short KM, Cox LL, Cox TC.

Mamm Genome. 2015 Feb;26(1-2):57-79. doi: 10.1007/s00335-014-9551-x. Epub 2015 Jan 1.

PMID:
25552398
[PubMed - in process]
7.

KAP1 Promotes Proliferation and Metastatic Progression of Breast Cancer Cells.

Addison JB, Koontz C, Fugett JH, Creighton CJ, Chen D, Farrugia MK, Padon RR, Voronkova MA, McLaughlin SL, Livengood RH, Lin CC, Ruppert JM, Pugacheva EN, Ivanov AV.

Cancer Res. 2015 Jan 15;75(2):344-55. doi: 10.1158/0008-5472.CAN-14-1561. Epub 2014 Nov 24.

PMID:
25421577
[PubMed - in process]
8.

Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.

Totoki Y, Tatsuno K, Covington KR, Ueda H, Creighton CJ, Kato M, Tsuji S, Donehower LA, Slagle BL, Nakamura H, Yamamoto S, Shinbrot E, Hama N, Lehmkuhl M, Hosoda F, Arai Y, Walker K, Dahdouli M, Gotoh K, Nagae G, Gingras MC, Muzny DM, Ojima H, Shimada K, Midorikawa Y, Goss JA, Cotton R, Hayashi A, Shibahara J, Ishikawa S, Guiteau J, Tanaka M, Urushidate T, Ohashi S, Okada N, Doddapaneni H, Wang M, Zhu Y, Dinh H, Okusaka T, Kokudo N, Kosuge T, Takayama T, Fukayama M, Gibbs RA, Wheeler DA, Aburatani H, Shibata T.

Nat Genet. 2014 Dec;46(12):1267-73. doi: 10.1038/ng.3126. Epub 2014 Nov 2.

PMID:
25362482
[PubMed - indexed for MEDLINE]
9.

Stromal TGF-β signaling induces AR activation in prostate cancer.

Yang F, Chen Y, Shen T, Guo D, Dakhova O, Ittmann MM, Creighton CJ, Zhang Y, Dang TD, Rowley DR.

Oncotarget. 2014 Nov 15;5(21):10854-69.

PMID:
25333263
[PubMed - in process]
Free PMC Article
10.

Androgen deprivation-induced NCoA2 promotes metastatic and castration-resistant prostate cancer.

Qin J, Lee HJ, Wu SP, Lin SC, Lanz RB, Creighton CJ, DeMayo FJ, Tsai SY, Tsai MJ.

J Clin Invest. 2014 Nov;124(11):5013-26. doi: 10.1172/JCI76412. Epub 2014 Oct 8.

PMID:
25295534
[PubMed - indexed for MEDLINE]
11.

Functional analysis of miR-34c as a putative tumor suppressor in high-grade serous ovarian cancer.

Yu Z, Kim J, He L, Creighton CJ, Gunaratne PH, Hawkins SM, Matzuk MM.

Biol Reprod. 2014 Nov;91(5):113. doi: 10.1095/biolreprod.114.121988. Epub 2014 Oct 1.

PMID:
25273528
[PubMed - in process]
12.

Loss of TRIM62 Expression Is an Independent Adverse Prognostic Factor in Acute Myeloid Leukemia.

Quintás-Cardama A, Zhang N, Qiu YH, Post S, Creighton CJ, Cortes J, Coombes KR, Kornblau SM.

Clin Lymphoma Myeloma Leuk. 2015 Feb;15(2):115-127.e15. doi: 10.1016/j.clml.2014.07.011. Epub 2014 Aug 12.

PMID:
25248926
[PubMed - in process]
13.

Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase.

Fu X, Creighton CJ, Biswal NC, Kumar V, Shea M, Herrera S, Contreras A, Gutierrez C, Wang T, Nanda S, Giuliano M, Morrison G, Nardone A, Karlin KL, Westbrook TF, Heiser LM, Anur P, Spellman P, Guichard SM, Smith PD, Davies BR, Klinowska T, Lee AV, Mills GB, Rimawi MF, Hilsenbeck SG, Gray JW, Joshi A, Osborne CK, Schiff R.

Breast Cancer Res. 2014 Sep 11;16(5):430. doi: 10.1186/s13058-014-0430-x.

PMID:
25212826
[PubMed - in process]
Free PMC Article
14.

The somatic genomic landscape of chromophobe renal cell carcinoma.

Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, Shen H, Buhay C, Kang H, Kim SC, Fahey CC, Hacker KE, Bhanot G, Gordenin DA, Chu A, Gunaratne PH, Biehl M, Seth S, Kaipparettu BA, Bristow CA, Donehower LA, Wallen EM, Smith AB, Tickoo SK, Tamboli P, Reuter V, Schmidt LS, Hsieh JJ, Choueiri TK, Hakimi AA; Cancer Genome Atlas Research Network, Chin L, Meyerson M, Kucherlapati R, Park WY, Robertson AG, Laird PW, Henske EP, Kwiatkowski DJ, Park PJ, Morgan M, Shuch B, Muzny D, Wheeler DA, Linehan WM, Gibbs RA, Rathmell WK, Creighton CJ.

Cancer Cell. 2014 Sep 8;26(3):319-30. doi: 10.1016/j.ccr.2014.07.014. Epub 2014 Aug 21.

PMID:
25155756
[PubMed - indexed for MEDLINE]
15.

VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.

Zhao D, Pan C, Sun J, Gilbert C, Drews-Elger K, Azzam DJ, Picon-Ruiz M, Kim M, Ullmer W, El-Ashry D, Creighton CJ, Slingerland JM.

Oncogene. 2014 Aug 25. doi: 10.1038/onc.2014.257. [Epub ahead of print]

PMID:
25151964
[PubMed - as supplied by publisher]
16.

Comprehensive molecular profiling of lung adenocarcinoma.

Cancer Genome Atlas Research Network.

Nature. 2014 Jul 31;511(7511):543-50. doi: 10.1038/nature13385. Epub 2014 Jul 9. Erratum in: Nature. 2014 Oct 9;514(7521):262. Rogers, K [corrected to Rodgers, K].

PMID:
25079552
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Increased Notch signalling inhibits anoikis and stimulates proliferation of prostate luminal epithelial cells.

Kwon OJ, Valdez JM, Zhang L, Zhang B, Wei X, Su Q, Ittmann MM, Creighton CJ, Xin L.

Nat Commun. 2014 Jul 22;5:4416. doi: 10.1038/ncomms5416.

PMID:
25048699
[PubMed - in process]
Free PMC Article
18.

Pathway-centric integrative analysis identifies RRM2 as a prognostic marker in breast cancer associated with poor survival and tamoxifen resistance.

Putluri N, Maity S, Kommagani R, Creighton CJ, Putluri V, Chen F, Nanda S, Bhowmik SK, Terunuma A, Dorsey T, Nardone A, Fu X, Shaw C, Sarkar TR, Schiff R, Lydon JP, O'Malley BW, Ambs S, Das GM, Michailidis G, Sreekumar A.

Neoplasia. 2014 May;16(5):390-402. doi: 10.1016/j.neo.2014.05.007. Erratum in: Neoplasia. 2014 Aug;16(8):678. Kommangani, Ramakrishna [corrected to Kommagani, Ramakrishna].

PMID:
25016594
[PubMed - in process]
Free PMC Article
19.

Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer.

Guzel E, Karatas OF, Semercioz A, Ekici S, Aykan S, Yentur S, Creighton CJ, Ittmann M, Ozen M.

Int J Cancer. 2015 Feb 15;136(4):875-9. doi: 10.1002/ijc.29054. Epub 2014 Jul 7.

PMID:
24976077
[PubMed - indexed for MEDLINE]
20.

miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancer.

Karatas OF, Guzel E, Suer I, Ekici ID, Caskurlu T, Creighton CJ, Ittmann M, Ozen M.

PLoS One. 2014 Jun 26;9(6):e98675. doi: 10.1371/journal.pone.0098675. eCollection 2014.

PMID:
24967583
[PubMed - in process]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk